Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Receivables Refunds (2016 - 2022)

Usana Health Sciences (USNA) has disclosed Receivables Refunds for 10 consecutive years, with $1.6 million as the latest value for Q1 2022.

  • Quarterly Receivables Refunds rose 35.19% to $1.6 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Jan 2022, up 35.19% year-over-year, with the annual reading at $1.6 million for FY2022, 35.19% up from the prior year.
  • Receivables Refunds for Q1 2022 was $1.6 million at Usana Health Sciences, up from $1.2 million in the prior quarter.
  • The five-year high for Receivables Refunds was $6.4 million in Q4 2018, with the low at $1.2 million in Q1 2021.
  • Average Receivables Refunds over 4 years is $2.8 million, with a median of $1.8 million recorded in 2019.
  • The sharpest move saw Receivables Refunds plummeted 68.1% in 2019, then skyrocketed 35.19% in 2022.
  • Over 4 years, Receivables Refunds stood at $6.4 million in 2018, then tumbled by 68.1% to $2.0 million in 2019, then plummeted by 42.8% to $1.2 million in 2021, then surged by 35.19% to $1.6 million in 2022.
  • According to Business Quant data, Receivables Refunds over the past three periods came in at $1.6 million, $1.2 million, and $2.0 million for Q1 2022, Q1 2021, and Q4 2019 respectively.